Biggest healthcare deals of 2018

Amy Baxter | | Health Exec | Policy & Regulations

The global healthcare industry continued its hot streak in 2018, with bigger transactions that could reshape the landscape.

In a period of rapid consolidation across the industry, transaction volume is expected to remain high next year, as well. While volume soared in 2018, a number of large transaction marked the year.

Here are the biggest international healthcare deals of 2018, as ranked by Business Insider:

  1. Takeda’s (Japan) $77 billion acquisition of Shire (United States)
  2. Cigna’s $67 billion takeover of Express Scripts (United States)
  3. GlaxoSmithKline’s (UK) $13 billion stake in Novartis (Switzerland)
  4. Sanofi’s (France) $11 billion purchase of Bioverativ (United States)
  5. KKR’s $10 billion acquisition of Envision (United States)
  6. Celgene’s $9 billion acquisition of Juno (United States)
  7. Novartis’ (Switzerland) $8 billion purchase of AveXis (Unites States)

See the full story below:

Healthcare deals hit an all-time record in 2018. See the 7 biggest tie-ups that…

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

HHS employees offered two months of pay to quit their jobs
To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
CMS ends ACA special enrollment, changes deadline for signing up
Report: NIH continues to pull research grants, in violation of court orders
HHS sends 80K workers a $25K ‘voluntary’ resignation notice
More than 1,000 hospitals earn $700M opioid crisis judgment

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.